Deep learning-based platform that processes retinal images to assess cardiovascular, kidney, and eye disease risks. Trained on over 2.1 million clinical data points across diverse populations and imaging devices for robust, generalizable diagnostic performance.
Manufactured by
Mediwhale Inc.
Seoul, South Korea
The first comprehensive AI diagnostic solution Dr. Noon is the first comprehensive AI diagnostic solution to predict cardiovascular, kidney, eye diseases, and biological age through retinal images as a biomarker. Mediwhale is turning simple and effective AI diagnostic solutions into reality, empowering everyone to benefit from preventive healthcare.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Optain Health
Australia · 1 relevant product
CHECK-EYE
Germany · 2 relevant products
Aireen a.s.
Czech Republic · 3 relevant products
19 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →5 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 28 closest product alternatives
Optain Health · Australia
AI-powered platform that analyzes retinal images to identify early signs of eye diseases and assess cardiovascular disease risk. The system provides standardized risk assessment reporting to support clinical decision-making and reduce missed diagnoses.
CHECK-EYE · Germany
AI-powered platform for early detection of retinal changes and diabetic retinopathy. Analyzes fundus photographs to identify pathological changes at early stages before symptom onset. Results are generated within minutes and reviewed by medical professionals.
Aireen a.s. · Czech Republic
Diagnostic system analyzing retinal biomarkers and vascular damage from fundus photographs to assess risk of cardiovascular events. Evaluates stroke and ischemic heart disease risk through automated retinal image analysis in patients with vascular disease. Supports preventive cardiology and risk stratification.
25 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products